103
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Nimbandiolactone-21 and nimbandioloxyfuran, two new 28-norlimonoids from the leaves of Azadirachta indica (Meliaceae)

, ORCID Icon, , , , , & show all
Pages 867-872 | Received 27 Mar 2018, Accepted 10 May 2018, Published online: 09 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Duc Minh Nguyen Huu, Phu Hoang Dang, Ngoc Vinh Huynh, Huu Phuc Dang, Loi Vuong & Thi Lien Thuong Nguyen. (2021) Pipercyclobutanamide D, a new member of the cyclobutanamide-type alkaloid, from the roots of Piper nigrum. Journal of Asian Natural Products Research 23:9, pages 906-912.
Read now

Articles from other publishers (3)

Tran Trung Hieu, Phan Thi Thuy & Dau Xuan Duc. (2022) Isolation and Bioactivities of Limonoids from Meliaceae Family: A Review . Current Organic Chemistry 26:14, pages 1359-1430.
Crossref
Jun Luo, Yunpeng Sun, Qiurong Li & Lingyi Kong. (2022) Research progress of meliaceous limonoids from 2011 to 2021. Natural Product Reports 39:6, pages 1325-1365.
Crossref
Yunpeng Sun, Qiurong Li, Yujin Sun, Letian Cui, Yingying Wang, Yongyi Li, Jun Luo & Lingyi Kong. (2021) Limonoids with Diverse Oxidation Patterns of C-12 Indicating a Complete Ring C- seco Biogenetic Pathway from Munronia unifoliolata . Journal of Natural Products 84:8, pages 2352-2365.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.